CD4 and cervical cancer: There is, however, evidence in other African populations to suggest that only a small fraction of women with HIV/HPV are likely to develop invasive cervical cancer without influence from CD4+ count, thus pointing to an increased role of the other competing risk factors and the need to interrogate them as potential HPV persistence drivers, including host genetics [73–82].